Cancer’s Secret Weapon? Scientists Reveal How Tumors “Learn” To Survive Treatment

NYU Langone Health scientists propose a model for cancer drug resistance driven by AP-1–guided gene reprogramming.

Cancer cells may rapidly test different survival states during therapy, then lock in resistant patterns that can pass to daughter cells.

The findings, discussed in a Nature perspective, suggest resistance may arise through reversible gene-expression shifts, not only DNA mutations.

If confirmed, the model could lead to new ways to block tumors from adapting to chemotherapy.